Patient-friendly dry powder inhaler for Pumactant in seasonal allergic asthma

Investigation of a high dose dry powder inhaler (PADD: pressurised aerosol dry-powder delivery) has lead to consideration of incorporating important design features for the delivery of Pumactant, a high-dose, and highly cohesive lung surfactant.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2005-02, Vol.115 (2), p.S7-S7
Main Author: Dockhorn, R.J.
Format: Article
Language:English
Subjects:
Asthma
Drug dosages
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Investigation of a high dose dry powder inhaler (PADD: pressurised aerosol dry-powder delivery) has lead to consideration of incorporating important design features for the delivery of Pumactant, a high-dose, and highly cohesive lung surfactant.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2004.12.042